Marsh and the Drug Development Industry

Marsh's picture
Printer-friendly versionPrinter-friendly version
This explains the risk issues that arise at each stage of the development of a drug or medicinal product by organisations such as:

  • Academic institutions.
  • Pharmaceutical or biotechnology companies.
  • Providers of healthcare services.
  • Organisations involved in the development of drugs or medicinal products.

An explanation is given of the types of risk scenarios that can exist or be caused, how they can be controlled or treated and how an insurance solution with supporting risk management services can be created.

Some of the risk management tools that can be used, such as benchmarking of insurance limits, databases of claims or global clinical trials legislation and regulations and risk maps, are referenced as examples of the Marsh Value Proposition for the life science industry.

Copy this html code to your website/blog to embed this press release.


Post new comment

3 + 9 =

To prevent automated spam submissions leave this field empty.
Page execution time was 9529.35 ms.

Memory usage:

Memory used at: devel_init()=2.13 MB, devel_shutdown()=22.39 MB.